Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis.
Interferons are biological molecules with antiviral, antiproliferative, and immunomodulatory actions. Interferon alpha (IFN-alpha) and -beta are potentially useful in the treatment of multiple sclerosis (MS). IFN-gamma, in contrast, increases the frequency of exacerbations of MS. In this study, we compared the effect of recombinant human IFN-alpha, -beta, and -gamma on suppressor function in patients with MS. Nonspecific suppressor cell function, measured in a concanavalin A suppressor assay, was significantly decreased in 16 patients with progressive MS (mean percent suppression +/- SEM, 14.4 +/- 5.5 in patients with MS, 33.5 +/- 4.8 in 16 normal subjects; p less than 0.001). Recombinant human IFN-beta augmented suppressor function in MS to 45.4 +/- 5.1% (p less than 0.001) and in control subjects to 56.8 +/- 3.8% (p less than 0.001). Similarly, recombinant human IFN-alpha improved suppression in MS to 43.0 +/- 5.6% (p less than 0.001) and in control subjects to 51.1 +/- 5.9% (p less than 0.001). In contrast, recombinant human IFN-gamma had no effect on suppressor function in patients with MS and in control subjects. This study shows that IFN-alpha and -beta augment deficient suppressor function in MS, whereas IFN-gamma has no effect on suppressor function in the progressive phase of the disease.
Noronha
A
A
Department of Neurology, University of Chicago, IL 60637.
Toscas
A
A
Jensen
M A
MA
D000328:Adult; D003208:Concanavalin A / Q000494:pharmacology; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007155:Immunologic Factors / Q000494:pharmacology*; D007371:Interferon-gamma / Q000009:adverse effects; D007372:Interferons / Q000494:pharmacology*; D008213:Lymphocyte Activation; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000276:immunology* / Q000473:pathology; D011994:Recombinant Proteins / Q000494:pharmacology; D013268:Stimulation, Chemical; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects* / Q000276:immunology
D007155:Immunologic Factors; D011994:Recombinant Proteins; D003208:Concanavalin A; D007371:Interferon-gamma; D007372:Interferons